2019
Worldwide interest in our findings concerning preeclampsia, amlodipine
Our discoveries concerning preeclampsia, AT1-B2-receptor heterodimers and amlodipine have gained widespread attention worldwide. The leading Chinese news portal xw.qq.com (Tencent QQ), which is one of the ten most visited domains in the world, published an article explaining our findings concerning preeclampsia.
Review on Landmark Discovery of GPCR heterodimers published by Prof. Quitterer in 2019
The history leading to our landmark discovery of pathologic GPCR aggregation was recently published
Congratulations to the finding of pathologic and mechanosensitive AT1-B2 receptor heterodimers
We discovered that the most frequent pregnancy-specific disease, pre-eclampsia, can be alleviated by targeting of mechano-sensitive AT1-B2 receptor heterodimers. Our landmark discovery has been published in "Cell" (Vol. 176, pp. 318-333, 2019)